Table 1 The clinical characteristics of enrolled individuals in this study
Characteristic | Serum specimen | Tissue specimen | |||
|---|---|---|---|---|---|
CRC (n = 95) | CRP (n = 29) | HC (n = 56) | CRC (n = 34) | HC (n = 8) | |
Gender | |||||
 Male (n,%) | 52 (54.7%) | 17 (58.6%) | 24 (42.8%) | 21 (61.8%) | 6 (75%) |
 Female (n,%) | 43 (45.3%) | 12 (41.4%) | 32 (57.2%) | 13 (38.2%) | 2 (25%) |
Age | |||||
  < 60 (n,%) | 38 (40%) | 14 (48.3%) | 50 (89.3%) | 16 (47.1%) | 3 (37.5%) |
  ≥ 60 (n,%) | 57 (60%) | 15 (51.7%) | 6 (10.7%) | 18 (52.9%) | 5 (62.5%) |
Location | |||||
 Colon (n,%) | 47 (49.5%) | 24 (80%) | NA | 12 (35.3%) | NA |
 Rectum (n,%) | 48 (50.5%) | 5 (20%) | NA | 22 (64.7%) | NA |
Differentiation | |||||
 Poorly (n,%) | 31 (32.6%) | NA | NA | 8(23.5%) | NA |
 Well + Moderately (n,%) | 64 (67.4%) | NA | NA | 26(76.5%) | NA |
TNM stage | |||||
 I + II (n,%) | 45 (47.4%) | NA | NA | 11 (32.3%) | NA |
 III + IV (n,%) | 50 (52.6%) | NA | NA | 23 (67.6%) | NA |
Metastasis | |||||
 Present (n,%) | 50 (52.6%) | NA | NA | 14 (41.2%) | NA |
 Absent (n,%) | 45 (47.4%) | NA | NA | 20 (58.8%) | NA |